# Aerogen Nebuliser Versus Standard Nebulised Therapy in Acute Chronic Obstructive Pulmonary Disease

> **NCT02379065** · NA · COMPLETED · sponsor: **Chelsea and Westminster NHS Foundation Trust** · enrollment: 22 (actual)

## Conditions studied

- COPD

## Interventions

- **DEVICE:** The Aerogen Aeroneb Solo©
- **DEVICE:** Phillips Respironic© mask

## Key facts

- **NCT ID:** NCT02379065
- **Lead sponsor:** Chelsea and Westminster NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2017-10-20
- **Final completion:** 2017-10-20
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2021-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02379065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02379065, "Aerogen Nebuliser Versus Standard Nebulised Therapy in Acute Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02379065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*